Secteur Taysha Gene Therapies, Inc.

Actions

TSHA

US8776191061

Recherche biotechnologique et médicale

Temps réel estimé Cboe BZX 17:01:26 24/07/2026 Varia. 5j. Varia. 1 janv.
5,505 USD -5,57% Graphique intraday de Taysha Gene Therapies, Inc. -6,96% +0,82%
Principaux concurrents
Varia. Varia. 5j. Variation 1 mois Variation 3 mois Varia. 1 janv. Varia. 1an Varia. 3ans Varia. 5ans Varia. 10ans Capi.($)
-5,57%-6,96%-20,10%-13,36%+0,82%+114,09%+727,86%-69,11% - 1,86 Md
+1,23%+0,35%+19,89%+27,21%+40,61%+51,62%+87,98%-17,24% - 55,92 Md
+0,88%+6,99%+7,48%+20,77%+12,25%+62,87%+68,01%+207,33%+6 094,00% 56,67 Md
-3,07%-2,06%-0,68%-15,04%-5,88%-21,79%-16,29%-68,70% - 23,28 Md
-1,51%-1,98%+2,62%-21,45%-39,00%+2,56%+418,91%+344,23%+859,08% 23,28 Md
-0,36%-0,56%+25,56%+15,27%+24,36%+36,00%-3,93%-69,85% - 20,54 Md
-1,34%+0,40%+9,99%+9,67%-7,42%+24,89%-30,35%-33,01%+63,89% 17,78 Md
-1,44%-1,63%+29,15%+10,63%+31,06%+37,07%+589,93% - - 15,9 Md
-2,54%-8,73%+16,50%+102,81%+171,42%+164,11%+289,45%+1 516,04%+611,38% 14,64 Md
-0,72%-1,22%+4,48%+22,92%+26,03%+23,33%+177,73%+234,59%+534,21% 13,99 Md
-0,72%+16,20%+8,18%+16,82%+30,05%+431,00%+146,26%+29,39%+1 428,14% 12,22 Md
-0,04%-2,06%+6,34%+5,79%-6,92%+81,19%+163,55%+534,58% - 12,53 Md
-3,21%-2,26%+16,37%-23,70%-11,95%-30,61%+167,47%+87,91% - 12,08 Md
-8,51%-0,40%-3,47%-37,70%-21,36%-50,11%+591,21%+80,28%+92,38% 11,63 Md
-0,50%+1,97%+0,69%+25,17%+28,67%+119,14%+148,59%+189,93%+727,53% 11,12 Md
-4,70%-2,12%+24,46%-20,53%+15,56%+25,11%+91,26%-12,93% - 8,82 Md
+0,13%-0,11%+131,52%+118,54%+79,95%+175,45%+351,81%+355,49% - 8,82 Md
+0,68%+0,77%+17,12%+44,98%+208,32%+473,89%+584,78%-37,75%-10,42% 8,79 Md
-5,08%+0,37%+42,06%+29,25%+19,60%+29,67%+342,17%+331,45% - 8,27 Md
-1,82%-2,46%+1,76%-7,85%+18,81%+51,27%+15,92%+142,35% - 8,03 Md
Moyenne -1,86%+2,92%+17,00%+15,51%+30,75%+90,04%+245,62%+197,10%+1 155,58% 17,31 Md
Moyenne pondérée par Capi. -0,94%+3,76%+15,16%+16,11%+25,57%+69,23%+177,31%+176,42%+2 406,70%
Médicaments bio-thérapeutiques
  1. Bourse
  2. Actions
  3. Action TSHA
  4. Secteur Taysha Gene Therapies, Inc.